Also Plk1 has been reported to be regulated by E2F3 in bladder cancer cells in addition to known E2F3 targets such as Cyclin A and novel targets including pituitary tumor transforming gene 1 (PTTG1), and Caveolin-2 [25]. The gene discussed is E2F3; the disease is urinary bladder carcinoma.